Search Fred Hutch Extranet
For research participants who do not speak and/or read English, a short-form consent should be used (Office for Human Research Protections 45CFR46.117(b)(2)); U.S. Food and Drug Administration 21CFR50.25 and 50.27(b)(2)). The short-form is used to document that the elements of informed consent were orally presented to the research participant by a qualified interpreter. Both the short form and a written summary, which may also be the IRB-approved English-language informed consent document, must be submitted to the IRB.
NOTE: You must receive IRB approval to use these forms to consent participants.
There are two versions of the short-form consents are available, please use the version appropriate for your study.
Click below to access the version of the short-form consents for all research studies that were approved by the IRB on or after January 21, 2019.
Click below to access the version of the short-form consents for all research studies that were approved by the IRB before January 21, 2019.